mas.to

4 posts4 participants0 posts today

Miguel Afonso Caetano"Donald Trump’s tariffs demand a response. Around the world, that response has defaulted to retaliatory tariffs — a strategy with severe and obvious drawbacks. After years of pandemic shocks and greedflation, people around the globe have severe inflation fatigue, and few governments are eager to risk further price hikes. And while the world is rightly furious at Trump’s talk of annexation and other belligerent acts, that anger is unlikely to translate into popular support for higher prices on everyday goods. If there’s one lesson that politicians everywhere have metabolized over the past twenty-four months, it’s that any government that presides over inflationary price rises is likely to be out of a job come the next election.Luckily there is another policy response to tariffs — one that will substantially lower prices for America’s tariff-clobbered trading partners while incubating profitable, export-oriented domestic tech firms. These firms could sell tools and services to local businesses, to the benefit of the world’s news and culture industries, software firms, and consumers alike.That response? Repealing “anticircumvention laws” that prohibits domestic firms from reverse-engineering “digital locks.” These anticircumvention laws stop the world’s farmers from fixing their John Deere tractors; they stop mechanics from diagnosing your car; they stop technologists from creating their own app stores for phones and games consoles."<a href="https://jacobin.com/2025/04/ip-anticircumvention-tech-trump-tariffs" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://jacobin.com/2025/04/ip-anticircumvention-tech-trump-tariffs</a><a href="https://tldr.nettime.org/tags/USA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#USA</a> <a href="https://tldr.nettime.org/tags/Trump" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Trump</a> <a href="https://tldr.nettime.org/tags/Tariffs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Tariffs</a> <a href="https://tldr.nettime.org/tags/IP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#IP</a> <a href="https://tldr.nettime.org/tags/Copyright" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Copyright</a> <a href="https://tldr.nettime.org/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Patents</a> <a href="https://tldr.nettime.org/tags/AnticircumventionLaws" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#AnticircumventionLaws</a> <a href="https://tldr.nettime.org/tags/ReverseEngineering" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ReverseEngineering</a> <a href="https://tldr.nettime.org/tags/DRM" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#DRM</a>

Healthcare Tech RobotDATE: April 11, 2025 at 07:00AM SOURCE: BioWorld MedTechDirect article link at end of text block below.Patent filed for multiweek, multitarget <a href="https://mastodon.clinicians-exchange.org/tags/CGM" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CGM</a>-like <a href="https://mastodon.clinicians-exchange.org/tags/wearable" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#wearable</a> sensor<a href="https://t.co/TVeU62W0dG" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/TVeU62W0dG</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a> <a href="https://mastodon.clinicians-exchange.org/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a>Here are any URLs found in the article text: <a href="https://t.co/TVeU62W0dG" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/TVeU62W0dG</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>Articles can be found by scrolling down the page at <a href="https://www.bioworld.com/topics/85-bioworld-medtech" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.bioworld.com/topics/85-bioworld-medtech</a> . -------------------------------------------------Private, vetted email list for mental health professionals: <a href="https://www.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.clinicians-exchange.org</a> . NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at <a href="https://mastodon.clinicians-exchange.org/@PsychResearchBot" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@PsychResearchBot</a> . Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: <a href="https://www.nationalpsychologist.com" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.nationalpsychologist.com</a> . EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: <a href="http://subscribe-article-digests.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://subscribe-article-digests.clinicians-exchange.org</a> . READ ONLINE: <a href="http://read-the-rss-mega-archive.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://read-the-rss-mega-archive.clinicians-exchange.org</a> . It's primitive... but it works... mostly... . -------------------------------------------------<a href="https://mastodon.clinicians-exchange.org/tags/healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcare</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthcaretech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcaretech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtechnology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtechnology</a> <a href="https://mastodon.clinicians-exchange.org/tags/medgadget" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medgadget</a> <a href="https://mastodon.clinicians-exchange.org/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicine</a> <a href="https://mastodon.clinicians-exchange.org/tags/doctor" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#doctor</a> <a href="https://mastodon.clinicians-exchange.org/tags/hospital" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#hospital</a> <a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>

Healthcare Tech RobotDATE: April 10, 2025 at 04:00PM SOURCE: BioWorld MedTechDirect article link at end of text block below.Patent filed for multiweek, multitarget <a href="https://mastodon.clinicians-exchange.org/tags/CGM" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CGM</a>-like <a href="https://mastodon.clinicians-exchange.org/tags/wearable" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#wearable</a> sensor<a href="https://t.co/TVeU62W0dG" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/TVeU62W0dG</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a> <a href="https://mastodon.clinicians-exchange.org/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a>Here are any URLs found in the article text: <a href="https://t.co/TVeU62W0dG" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/TVeU62W0dG</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>Articles can be found by scrolling down the page at <a href="https://www.bioworld.com/topics/85-bioworld-medtech" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.bioworld.com/topics/85-bioworld-medtech</a> . -------------------------------------------------Private, vetted email list for mental health professionals: <a href="https://www.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.clinicians-exchange.org</a> . NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at <a href="https://mastodon.clinicians-exchange.org/@PsychResearchBot" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@PsychResearchBot</a> . Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: <a href="https://www.nationalpsychologist.com" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.nationalpsychologist.com</a> . EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: <a href="http://subscribe-article-digests.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://subscribe-article-digests.clinicians-exchange.org</a> . READ ONLINE: <a href="http://read-the-rss-mega-archive.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://read-the-rss-mega-archive.clinicians-exchange.org</a> . It's primitive... but it works... mostly... . -------------------------------------------------<a href="https://mastodon.clinicians-exchange.org/tags/healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcare</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthcaretech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcaretech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtechnology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtechnology</a> <a href="https://mastodon.clinicians-exchange.org/tags/medgadget" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medgadget</a> <a href="https://mastodon.clinicians-exchange.org/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicine</a> <a href="https://mastodon.clinicians-exchange.org/tags/doctor" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#doctor</a> <a href="https://mastodon.clinicians-exchange.org/tags/hospital" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#hospital</a> <a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>

Healthcare Tech RobotDATE: April 09, 2025 at 06:30AM SOURCE: BioWorld MedTechDirect article link at end of text block below.Researchers use <a href="https://mastodon.clinicians-exchange.org/tags/generativeAI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generativeAI</a> for <a href="https://mastodon.clinicians-exchange.org/tags/autism" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#autism</a> <a href="https://mastodon.clinicians-exchange.org/tags/diagnosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#diagnosis</a><a href="https://t.co/vvAe2DJy3o" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/vvAe2DJy3o</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a> <a href="https://mastodon.clinicians-exchange.org/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a> @GWtweetsHere are any URLs found in the article text: <a href="https://t.co/vvAe2DJy3o" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/vvAe2DJy3o</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>Articles can be found by scrolling down the page at <a href="https://www.bioworld.com/topics/85-bioworld-medtech" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.bioworld.com/topics/85-bioworld-medtech</a> . -------------------------------------------------Private, vetted email list for mental health professionals: <a href="https://www.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.clinicians-exchange.org</a> . NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at <a href="https://mastodon.clinicians-exchange.org/@PsychResearchBot" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@PsychResearchBot</a> . Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: <a href="https://www.nationalpsychologist.com" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.nationalpsychologist.com</a> . EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: <a href="http://subscribe-article-digests.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://subscribe-article-digests.clinicians-exchange.org</a> . READ ONLINE: <a href="http://read-the-rss-mega-archive.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://read-the-rss-mega-archive.clinicians-exchange.org</a> . It's primitive... but it works... mostly... . -------------------------------------------------<a href="https://mastodon.clinicians-exchange.org/tags/healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcare</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthcaretech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcaretech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtechnology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtechnology</a> <a href="https://mastodon.clinicians-exchange.org/tags/medgadget" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medgadget</a> <a href="https://mastodon.clinicians-exchange.org/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicine</a> <a href="https://mastodon.clinicians-exchange.org/tags/doctor" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#doctor</a> <a href="https://mastodon.clinicians-exchange.org/tags/hospital" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#hospital</a> <a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>

Healthcare Tech RobotDATE: April 08, 2025 at 05:30PM SOURCE: BioWorld MedTechDirect article link at end of text block below.Researchers use <a href="https://mastodon.clinicians-exchange.org/tags/generativeAI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generativeAI</a> for <a href="https://mastodon.clinicians-exchange.org/tags/autism" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#autism</a> <a href="https://mastodon.clinicians-exchange.org/tags/diagnosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#diagnosis</a><a href="https://t.co/vvAe2DJy3o" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/vvAe2DJy3o</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a> <a href="https://mastodon.clinicians-exchange.org/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a> @GWtweetsHere are any URLs found in the article text: <a href="https://t.co/vvAe2DJy3o" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/vvAe2DJy3o</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>Articles can be found by scrolling down the page at <a href="https://www.bioworld.com/topics/85-bioworld-medtech" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.bioworld.com/topics/85-bioworld-medtech</a> . -------------------------------------------------Private, vetted email list for mental health professionals: <a href="https://www.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.clinicians-exchange.org</a> . NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at <a href="https://mastodon.clinicians-exchange.org/@PsychResearchBot" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@PsychResearchBot</a> . Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: <a href="https://www.nationalpsychologist.com" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.nationalpsychologist.com</a> . EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: <a href="http://subscribe-article-digests.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://subscribe-article-digests.clinicians-exchange.org</a> . READ ONLINE: <a href="http://read-the-rss-mega-archive.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://read-the-rss-mega-archive.clinicians-exchange.org</a> . It's primitive... but it works... mostly... . -------------------------------------------------<a href="https://mastodon.clinicians-exchange.org/tags/healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcare</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthcaretech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcaretech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtechnology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtechnology</a> <a href="https://mastodon.clinicians-exchange.org/tags/medgadget" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medgadget</a> <a href="https://mastodon.clinicians-exchange.org/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicine</a> <a href="https://mastodon.clinicians-exchange.org/tags/doctor" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#doctor</a> <a href="https://mastodon.clinicians-exchange.org/tags/hospital" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#hospital</a> <a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>

Catharina Bethlehem ☑️ Cath<a href="https://mastodon.nl/@jurjen_heeck" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@jurjen_heeck</a> Wat vind je hier van? <a href="https://gross.substack.com/p/the-smart-way-to-retaliate-against" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://gross.substack.com/p/the-smart-way-to-retaliate-against</a><a href="https://mastodon.social/tags/Trump" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Trump</a> <a href="https://mastodon.social/tags/Tarrifs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Tarrifs</a> <a href="https://mastodon.social/tags/IP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#IP</a> <a href="https://mastodon.social/tags/Copyright" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Copyright</a> <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Patents</a>

your auntifa liza 🇵🇷 🦛 🦦DEAR <a href="https://mastodon.social/tags/IP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#IP</a> <a href="https://mastodon.social/tags/PATENT" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PATENT</a> LAWYERS, am still watching pre-code movies, particularly movies around 1928 the year Jazz Man came out and talkies became a thing. one thing i’ve noticed are the big PATENT NOTICES at the beginning of talkies. that has made me wonder: i have not noticed patent notices at the beginning of silent movies. so i ask: is this why there were a fuckton of independent silent film makers? did sound film <a href="https://mastodon.social/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a> help concentrate power into the Hollywood studios monopsony?

Healthcare Tech RobotDATE: April 03, 2025 at 09:00AM SOURCE: BioWorld MedTechDirect article link at end of text block below..@Medtronic , @ReCorMedical commence hostilities over @RDN <a href="https://mastodon.clinicians-exchange.org/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a><a href="https://t.co/s1L0uuMLNf" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/s1L0uuMLNf</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>Here are any URLs found in the article text: <a href="https://t.co/s1L0uuMLNf" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/s1L0uuMLNf</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>Articles can be found by scrolling down the page at <a href="https://www.bioworld.com/topics/85-bioworld-medtech" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.bioworld.com/topics/85-bioworld-medtech</a> . -------------------------------------------------Private, vetted email list for mental health professionals: <a href="https://www.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.clinicians-exchange.org</a> . NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at <a href="https://mastodon.clinicians-exchange.org/@PsychResearchBot" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@PsychResearchBot</a> . Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: <a href="https://www.nationalpsychologist.com" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.nationalpsychologist.com</a> . EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: <a href="http://subscribe-article-digests.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://subscribe-article-digests.clinicians-exchange.org</a> . READ ONLINE: <a href="http://read-the-rss-mega-archive.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://read-the-rss-mega-archive.clinicians-exchange.org</a> . It's primitive... but it works... mostly... . -------------------------------------------------<a href="https://mastodon.clinicians-exchange.org/tags/healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcare</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthcaretech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcaretech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtechnology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtechnology</a> <a href="https://mastodon.clinicians-exchange.org/tags/medgadget" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medgadget</a> <a href="https://mastodon.clinicians-exchange.org/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicine</a> <a href="https://mastodon.clinicians-exchange.org/tags/doctor" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#doctor</a> <a href="https://mastodon.clinicians-exchange.org/tags/hospital" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#hospital</a> <a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>

JonI don't remember where I read this (some time ago), but I liked the suggestion.Instead of answering Trumps tariffs with another set of tariffs and thereby hurting their own population and economy, Europe (and the rest of the world) could answer by lifting the jurisdiction of US-patents. Patents only work when the local authorities actually uphold them.Especially in the case of software. Imagine how BigTech would react if they loose revenue.Does this make sense?<a href="https://oslo.town/tags/uspol" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#uspol</a> <a href="https://oslo.town/tags/tar" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#tar</a> <a href="https://oslo.town/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a>

Healthcare Tech RobotDATE: April 02, 2025 at 07:00PM SOURCE: BioWorld MedTechDirect article link at end of text block below..@Medtronic , @ReCorMedical commence hostilities over @RDN <a href="https://mastodon.clinicians-exchange.org/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a><a href="https://t.co/s1L0uuMdXH" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/s1L0uuMdXH</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>Here are any URLs found in the article text: <a href="https://t.co/s1L0uuMdXH" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://t.co/s1L0uuMdXH</a><a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>Articles can be found by scrolling down the page at <a href="https://www.bioworld.com/topics/85-bioworld-medtech" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.bioworld.com/topics/85-bioworld-medtech</a> . -------------------------------------------------Private, vetted email list for mental health professionals: <a href="https://www.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.clinicians-exchange.org</a> . NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at <a href="https://mastodon.clinicians-exchange.org/@PsychResearchBot" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@PsychResearchBot</a> . Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: <a href="https://www.nationalpsychologist.com" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.nationalpsychologist.com</a> . EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: <a href="http://subscribe-article-digests.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://subscribe-article-digests.clinicians-exchange.org</a> . READ ONLINE: <a href="http://read-the-rss-mega-archive.clinicians-exchange.org" rel="nofollow noopener noreferrer" translate="no" target="_blank">http://read-the-rss-mega-archive.clinicians-exchange.org</a> . It's primitive... but it works... mostly... . -------------------------------------------------<a href="https://mastodon.clinicians-exchange.org/tags/healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcare</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthcaretech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcaretech</a> <a href="https://mastodon.clinicians-exchange.org/tags/healthtechnology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthtechnology</a> <a href="https://mastodon.clinicians-exchange.org/tags/medgadget" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medgadget</a> <a href="https://mastodon.clinicians-exchange.org/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicine</a> <a href="https://mastodon.clinicians-exchange.org/tags/doctor" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#doctor</a> <a href="https://mastodon.clinicians-exchange.org/tags/hospital" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#hospital</a> <a href="https://mastodon.clinicians-exchange.org/tags/medtech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medtech</a>

Bytes EuropeLawmakers seek clarity on patents withdrawal from EU Industry Commissioner <a href="https://www.byteseu.com/887184/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.byteseu.com/887184/</a> <a href="https://pubeurope.com/tags/EUPolicy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EUPolicy</a> <a href="https://pubeurope.com/tags/Europe" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Europe</a> <a href="https://pubeurope.com/tags/industry" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#industry</a> <a href="https://pubeurope.com/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a> <a href="https://pubeurope.com/tags/St%C3%A9phaneS%C3%A9journ%C3%A9" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#StéphaneSéjourné</a>

PUPUWEB Blog<a href="https://mastodon.social/tags/Nokia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Nokia</a> and <a href="https://mastodon.social/tags/Amazon" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Amazon</a> settle their global patent dispute over Amazon using Nokia’s video tech in <a href="https://mastodon.social/tags/PrimeVideo" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PrimeVideo</a> & devices. The terms remain undisclosed. A major shift in the tech patent landscape! <a href="https://mastodon.social/tags/TechNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#TechNews</a> <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Patents</a> <a href="https://mastodon.social/tags/VideoTech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#VideoTech</a> <a href="https://mastodon.social/tags/AmazonPrime" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#AmazonPrime</a> <a href="https://mastodon.social/tags/Innovation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Innovation</a> <a href="https://mastodon.social/tags/LegalTech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#LegalTech</a>

PUPUWEB BlogUS judge dismisses Samsung's Oura lawsuit, ruling Samsung acted prematurely in seeking judgment that Galaxy Ring doesn't infringe Oura's patents. ⚖️ <a href="https://mastodon.social/tags/Samsung" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Samsung</a> <a href="https://mastodon.social/tags/Oura" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Oura</a> <a href="https://mastodon.social/tags/Lawsuit" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Lawsuit</a> <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Patents</a> <a href="https://mastodon.social/tags/TechNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#TechNews</a> <a href="https://mastodon.social/tags/LegalNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#LegalNews</a> <a href="https://mastodon.social/tags/GalaxyRing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GalaxyRing</a> <a href="https://mastodon.social/tags/IntellectualProperty" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#IntellectualProperty</a>

prabirkc<a href="https://www.himalmag.com/politics/india-pharma-regulation-drug-safety" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.himalmag.com/politics/india-pharma-regulation-drug-safety</a> <a href="https://mastodon.social/tags/India" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#India</a> <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Patents</a> <a href="https://mastodon.social/tags/Pharmaceuticals" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Pharmaceuticals</a> <a href="https://mastodon.social/tags/Law" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Law</a>

prabirkc<a href="https://www.himalmag.com/politics/bangladesh-pharma-patents-safety-regulation" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.himalmag.com/politics/bangladesh-pharma-patents-safety-regulation</a> <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Patents</a> <a href="https://mastodon.social/tags/Pharmaceuticals" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Pharmaceuticals</a>

Phil Baker :fedora: :freebsd:The tl;dr: As stated in the host's predictions section of the video, over the air (OTA) TV in the US will cease to exist and the spectrum sold off to the highest bidder. A completely avoidable situation, but <a href="https://fosstodon.org/tags/DRM" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#DRM</a> and <a href="https://fosstodon.org/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a> will end up killing something that Americans have taken for granted since the 1950s. <a href="https://fosstodon.org/tags/NextGenTV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#NextGenTV</a> <a href="https://youtu.be/sQVb62Cn_t8" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://youtu.be/sQVb62Cn_t8</a>

prabirkc<a href="https://www.twn.my/title2/health.info/2025/hi250304.htm" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.twn.my/title2/health.info/2025/hi250304.htm</a> <a href="https://mastodon.social/tags/Health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Health</a> <a href="https://mastodon.social/tags/HealthEconomics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#HealthEconomics</a> <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Patents</a> <a href="https://mastodon.social/tags/IPR" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#IPR</a> <a href="https://mastodon.social/tags/IntellectualProperty" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#IntellectualProperty</a> <a href="https://mastodon.social/tags/IntellectualPropertyRights" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#IntellectualPropertyRights</a>

Kevin Karhan :verified:<a href="https://mstdn.jp/@landley" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@landley</a> <a href="https://todon.nl/@burnoutqueen" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@burnoutqueen</a> Yeah...<a href="https://infosec.space/tags/GPLv3" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GPLv3</a> is a desaster as it's 99% ideology and 1% license text and alongside <a href="https://infosec.space/tags/AGPLv3" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#AGPLv3</a> completely ignores the reality of how <a href="https://infosec.space/tags/licensing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#licensing</a> and <a href="https://infosec.space/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a> and <a href="https://infosec.space/tags/IP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#IP</a> works.<ul><li>Not that I like the status-quo, but we'd rather see businesses steer clear of anything GPLv2+ or GPLv3 or worse.</li></ul>And on the flipside we basically get "source available" stuff like <a href="https://infosec.space/tags/SSPL" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SSPL</a> which only serves as a means to commit <a href="https://infosec.space/tags/AssetDenial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#AssetDenial</a> and monopolize commercial offerings...<ul><li>I think <a href="https://infosec.space/tags/Linux" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Linux</a> being <a href="https://infosec.space/tags/GPLv2only" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GPLv2only</a> is a good compromise and my personal gripes with <a href="https://infosec.space/tags/FSF" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#FSF</a> & <a href="https://infosec.space/tags/GNUtils" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GNUtils</a> as well as <a href="https://infosec.space/tags/GlibC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GlibC</a> are something different...</li></ul>

petersuberUpdate. New study: "<a href="https://fediscience.org/tags/NIH" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#NIH</a> investment in drugs approved from 2010 to 2019 was not less than investment by the <a href="https://fediscience.org/tags/pharmaceutical" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#pharmaceutical</a> industry, with comparable accounting for basic and applied research, failed clinical trials, and cost of capital or discount rates." <a href="https://jamanetwork.com/journals/jama-health-forum/fullarticle/2804378" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://jamanetwork.com/journals/jama-health-forum/fullarticle/2804378</a> PS: Relevant to (1) <a href="https://fediscience.org/tags/Trump" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Trump</a> admin cutbacks to NIH <a href="https://fediscience.org/tags/funding" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#funding</a> and (2) industry <a href="https://fediscience.org/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a> and licensing terms on approved drugs. <a href="https://fediscience.org/tags/Medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Medicine</a> <a href="https://fediscience.org/tags/Pharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Pharma</a>

Miguel Afonso Caetano"The U.S. Patent and Trademark Office (USPTO) just made a move that will protect bad patents at the expense of everyone else. In a memo released February 28, the USPTO further restricted access to inter partes review, or IPR—the process Congress created to let the public challenge invalid patents without having to wage million-dollar court battles.If left unchecked, this decision will shield bad patents from scrutiny, embolden patent trolls, and make it even easier for hedge funds and large corporations to weaponize weak patents against small businesses and developers."<a href="https://www.eff.org/deeplinks/2025/03/new-uspto-memo-makes-fighting-patent-trolls-even-harder" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.eff.org/deeplinks/2025/03/new-uspto-memo-makes-fighting-patent-trolls-even-harder</a><a href="https://tldr.nettime.org/tags/USA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#USA</a> <a href="https://tldr.nettime.org/tags/USPTO" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#USPTO</a> <a href="https://tldr.nettime.org/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Patents</a> <a href="https://tldr.nettime.org/tags/PatentTrolls" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PatentTrolls</a> <a href="https://tldr.nettime.org/tags/IP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#IP</a>

Recent searches

Search options

Administered by:

Server stats:

#patents